HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

5- (3- methyl- 1- triazeno)imidazole- 4- carboxamide (MTIC)

structure; RN given refers to parent cpd
Also Known As:
MTIC; 5-(3-methyl-1-triazeno)imidazole-4-carboxamide monohydrochloride; NSC 407347; NSC-407347
Networked: 24 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Du, Ke: 2 articles (12/2021 - 11/2019)
2. Feng, Fude: 2 articles (12/2021 - 11/2019)
3. Sun, Jian: 2 articles (12/2021 - 11/2019)
4. Fouladi, Maryam: 2 articles (01/2005 - 12/2003)
5. Gajjar, Amar: 2 articles (01/2005 - 12/2003)
6. Kirstein, Mark N: 2 articles (12/2003 - 11/2003)
7. Stewart, Clinton F: 2 articles (12/2003 - 11/2003)
8. Xia, Qiuyu: 1 article (12/2021)
9. Li, Xiao: 1 article (11/2019)
10. Shao, Fenli: 1 article (11/2019)

Related Diseases

1. Neoplasms (Cancer)
2. Glioma (Gliomas)
3. Melanoma (Melanoma, Malignant)
4. Glioblastoma (Glioblastoma Multiforme)
5. Leiomyosarcoma

Related Drugs and Biologics

1. Temozolomide (Temodar)
2. Proteins (Proteins, Gene)
3. Ligands
4. fucoidan
5. 5- (3- methyl- 1- triazeno)imidazole- 4- carboxamide (MTIC)
6. Dacarbazine (DIC)
7. imidazole-4-carboxamide
8. Prodrugs
9. Alkyl and Aryl Transferases
10. Vinblastine (Vinblastine Sulfate)

Related Therapies and Procedures

1. Therapeutics
2. Intraperitoneal Injections
3. Drug Therapy (Chemotherapy)
4. Oral Administration